LexAurum Advisors’s Inovio Pharmaceuticals INO Stock Holding History

LexAurum Advisors’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$118K	Buy	+97,100	New	+$108K	0.01%	414

Other funds holding INO

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Signature Estate & Investment Advisors Los Angeles, California $5.67B AUM 20.02% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Decker Retirement Planning Levi, Utah $302M AUM 70.25% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Rydar Equities Weatherford, Texas $194M AUM 23.21% 1-Year Est. Return

LexAurum Advisors's INO Position: Q3 2026 in Review

LexAurum Advisors opened a new position in Inovio Pharmaceuticals (INO) in Q3 2026: 97,100 shares worth $118K. The stake represents 0.01% of the portfolio and ranks #414 among its holdings.

19 funds tracked by Wall St. Rank hold INO as of Q3 2026.

LexAurum Advisors held 97,100 shares of Inovio Pharmaceuticals worth $118K as of Q3 2026.
Inovio Pharmaceuticals was a new LexAurum Advisors position in Q3 2026.
Inovio Pharmaceuticals made up 0.01% of LexAurum Advisors's portfolio in Q3 2026, its #414 holding.
19 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.

Based on LexAurum Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.